Ad is loading...
LAVTX
Price
$16.62
Change
-$0.07 (-0.42%)
Updated
Nov 15 closing price
RMFCX
Price
$58.23
Change
-$0.50 (-0.85%)
Updated
Nov 15 closing price
Ad is loading...

LAVTX vs RMFCX

Header iconLAVTX vs RMFCX Comparison
Open Charts LAVTX vs RMFCXBanner chart's image
Lord Abbett Fundamental Equity R5
Price$16.62
Change-$0.07 (-0.42%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$58.23
Change-$0.50 (-0.85%)
VolumeN/A
CapitalizationN/A
LAVTX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVTX vs. RMFCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVTX is a StrongBuy and RMFCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. LAVTX (2B). RMFCX pays higher dividends than LAVTX: RMFCX (1.69) vs LAVTX (0.94). LAVTX was incepted earlier than RMFCX: LAVTX (9 years) vs RMFCX (22 years). LAVTX (26.00) and RMFCX (25.00) have comparable annual turnover. LAVTX has a lower initial minimum investment than RMFCX: LAVTX (0) vs RMFCX (250). LAVTX annual gain was more profitable for investors over the last year : 32.03 vs. RMFCX (21.31). RMFCX return over 5 years is better than : 44.92 vs. LAVTX (32.37).
LAVTXRMFCXLAVTX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD23.66116.440144%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2B104B2%
Annual Yield % from dividends0.941.6956%
Returns for 1 year32.0321.31150%
Returns for 3 years9.9915.4665%
Returns for 5 years32.3744.9272%
Returns for 10 yearsN/A65.01-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS0.630.01
+1.10%
Momentus
WWW21.79-0.24
-1.09%
Wolverine World Wide
SNAP10.60-0.16
-1.49%
Snap
SHC14.31-0.68
-4.54%
Sotera Health Company
ENTA9.53-0.60
-5.92%
Enanta Pharmaceuticals